| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $148.4M | +1.2% | +15.3% |
| Cost of Revenue | $22.7M | +9.9% | +17.5% |
| R&D Expense | $2.7M | -39.0% | -19.1% |
| SG&A Expense | $47.5M | +3.3% | +3.5% |
| Operating Income | $66.3M | -0.0% | +30.2% |
| Pre-tax Income | $71.0M | +2.5% | +24.2% |
| Income Tax | $18.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $689.9M | +5.7% | +56.0% |
| Accounts Receivable | $106.4M | +61.6% | +82.6% |
| Inventory | $28.0M | +50.3% | +40.0% |
| Current Assets | $852.5M | +12.4% | +58.2% |
| Total Assets | $1.05B | +8.2% | +36.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $163.8M | — | — |
| Capital Expenditures | $26K | — | — |
| Investing Cash Flow | -$26K | — | — |
| Financing Cash Flow | $8.6M | — | — |
| Free Cash Flow | $163.8M | — | — |
| +6.2% |
| +37.0% |
| Net Income | $52.8M | +1.3% | +20.3% |
| EPS (Basic) | $0.43 | +0.0% | +16.2% |
| EPS (Diluted) | $0.42 | +2.4% | +20.0% |
| $128.7M |
| +13.9% |
| +22.1% |
| Total Liabilities | $131.4M | +13.3% | +18.3% |
| Stockholders' Equity | $920.2M | +7.5% | +39.2% |